PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs
22. März 2021 16:01 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., March 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient-Centric Trial Development Toolkit, available now to clinical...
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 Results
24. Februar 2021 06:04 ET
|
PRA Health Sciences, Inc.
Net new business of $872.4 million in the fourth quarter excluding reimbursement revenue; representing growth of 32.4%; Net book-to-bill of 1.42Net new business of $1,437.8 million in the fourth...
PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings
04. Februar 2021 13:01 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and full year 2020 results after the market closes on Thursday, February 25,...
PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities
17. Dezember 2020 16:02 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Dec. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the enhancement of its COVID-19 Monitoring Program with the addition of at-home COVID-19 testing...
PRA Health Sciences nomeia alto funcionário da FDA para liderar o novo Centro Global de Excelência da Estratégia de Testes Clínicos Descentralizados
23. November 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ: PRAH) anunciou hoje a nomeação de Isaac Rodriguez-Chávez, PhD, MHS, MS, como Vice-Presidente Sênior, Assuntos...
PRA Health Sciences melantik pegawai kanan FDA untuk mengetuai Pusat Kecemerlangan Global untuk Strategi Kajian Klinikal Terpencar
23. November 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) hari ini mengumumkan pelantikan Isaac Rodriguez-Chavez, PhD, MHS, MS sebagai Timbalan Presiden Kanan, Hal...
PRA 헬스사이언스, 새롭게 건립하는 Global Center of Excellence for Decentralized Clinical Trial Strategy 총괄할 FDA 고위 인사 영입
23. November 2020 14:28 ET
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ: PRAH))는 아이잭 로드리게스-차베스(Isaac Rodriguez-Chavez) 박사(공중보건학 석사, 이학 석사)를 과학, 임상 담당 부사장으로 선임한다고 발표했다....
PRAヘルスサイエンス、FDAシニアオフィサーを分散型臨床試験戦略のグローバル･センター･オブ･エクセレンス統括者に任命
23. November 2020 14:28 ET
|
PRA Health Sciences, Inc.
ノースカロライナ州ローリー発, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences, Inc.、NASDAQ: PRAH) は本日、アイザック･ロドリゲス･チャベス (Isaac Rodriguez-Chavez) 博士 (保健学修士、理学修士)...
PRA Health Sciences ernennt hochrangigen FDA-Beamten zum Leiter des neuen Global Center of Excellence for Decentralized Clinical Trial Strategy
23. November 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) gab heute die Ernennung von Isaac Rodriguez-Chavez, PhD, MHS, MS, zum Senior Vice President, Scientific and...
PRA Health Sciences nomme un haut responsable de la FDA pour diriger le nouveau Centre mondial d'excellence pour la stratégie d'essais cliniques décentralisés
23. November 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 23 nov. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination d'Isaac Rodriguez-Chavez, PhD, MHS, MME, au poste de...